ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.695
      -0.76%
      Bitcoin
      62,844.85
      -3.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Fibrocell Science Inc (FCSC)

      7. Fibrocell Science Inc (FCSC) News

      FCSC

      Fibrocell Science (FCSC)

      Fibrocell Science Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FCSC
      DateTimeSourceHeadlineSymbolCompany
      07/27/20164:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      07/27/20164:01PMGlobeNewswire Inc.Fibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epi...NASDAQ:FCSCFibrocell Science Inc
      07/12/20165:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      07/07/20164:05PMGlobeNewswire Inc.Fibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare ConferenceNASDAQ:FCSCFibrocell Science Inc
      06/30/20168:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      06/29/20164:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      06/29/20164:30PMGlobeNewswire Inc.Fibrocell Expects Significant Cost Savings from Wind-Down of azficel-T OperationsNASDAQ:FCSCFibrocell Science Inc
      06/27/20165:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      06/24/20164:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
      06/23/20164:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
      06/23/20164:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
      06/23/20164:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
      06/13/20168:00AMGlobeNewswire Inc.Fibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dyst...NASDAQ:FCSCFibrocell Science Inc
      06/08/20168:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      06/08/20168:00AMGlobeNewswire Inc.Fibrocell Reports Phase II azficel-T Trial for Treatment of Vocal Cord Scarring Did Not Meet Primary EndpointsNASDAQ:FCSCFibrocell Science Inc
      05/18/20168:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      05/05/20168:04AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FCSCFibrocell Science Inc
      05/05/20168:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      05/05/20168:00AMGlobeNewswire Inc.Fibrocell Reports First Quarter 2016 Financial Results and Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
      04/29/20166:06PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FCSCFibrocell Science Inc
      04/28/201611:46AMGlobeNewswire Inc.Fibrocell Receives Orphan Drug Designation from the FDA for FCX-013 for the Treatment of Localized SclerodermaNASDAQ:FCSCFibrocell Science Inc
      04/28/20168:00AMGlobeNewswire Inc.Fibrocell to Host Conference Call and Webcast on Thursday, May 5, 2016 to Discuss First Quarter 2016 Financial Results and R...NASDAQ:FCSCFibrocell Science Inc
      04/25/20168:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      04/21/20168:00AMGlobeNewswire Inc.Fibrocell Announces Last Patient Visit for Primary Endpoint Analysis in Phase II Clinical Trial of azficel-T for the Treatmen...NASDAQ:FCSCFibrocell Science Inc
      04/18/20165:22PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FCSCFibrocell Science Inc
      04/18/20168:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      04/18/20168:00AMGlobeNewswire Inc.Fibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic ...NASDAQ:FCSCFibrocell Science Inc
      03/15/20168:00AMGlobeNewswire Inc.Fibrocell to Present at the Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor DayNASDAQ:FCSCFibrocell Science Inc
      03/10/20168:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
      03/10/20168:00AMGlobeNewswire Inc.Fibrocell Reports Fourth Quarter and Full Year 2015 Financial Results and Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
       Showing the most relevant articles for your search:NASDAQ:FCSC